Colossal Biosciences has just had a major breakthrough in its attempt to revive the dodo bird from extinction. What are the ...

Delve into Eli Lilly’s biopharma strategy as it advances its pipeline, wins regulatory milestones, and forges strategic deals ...

Discover why the Netherlands is a leading hub for biotech clinical trials, with unique advantages, challenges, and strong ...

The paper mill was discovered by the research-integrity sleuth and scientist Anna Abalkina at the Free University of Berlin ...

The WHO has added GLP-1 agonists to its Essential Medicines List in 2025. Learn more about the impact of this decision.

At the European Cell & Gene Therapy Summit 2025, funding challenges and innovation drove discussions on the sector’s future.

Learn why rare diseases are more common in some communities due to cousin marriages and founder effects in population ...

The news that the organization led a $35 million funding round for London-based Portal Biotech came about two weeks ago. Portal Biotech’s focus is on the field of proteomics, which is the study of ...

In 2020, Novo Nordisk’s Canadian patent for semaglutide, the active ingredient in its blockbuster GLP-1 drugs Ozempic and Wegovy, quietly expired. The reason? A small missed maintenance fee, ...

We’re nearly halfway through 2025, and like clockwork, the American Society of Clinical Oncology (ASCO) annual summit took place from the 30th of May to the 3rd of June in Chicago this year. With ...